Redirecting to https://www.wallstreet-online.de/nachricht/20787571-erasca-announces-positive-preliminary-phase-1-dose-escalation-data-for-potentially-best-in-class-pan-ras-molecular-glue-eras-0015-kras-mutant-solid-tumors